Skip to main content

Fennec Pharmaceuticals Inc(FRX-T)
TSX

Today's Change
Real-Time Last Update
Day Low9.13
Day High9.66
Open:9.66
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Select a category then submit the form to load news
GlobeNewswire
Fennec Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
Fennec Pharmaceuticals to Report First Quarter 2024 Financial Results onย May 14, 2024
Baystreet
Stocks in play: Fennec Pharmaceuticals Inc.
GlobeNewswire
Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business Update
Baystreet
Stocks in play: Fennec Pharmaceuticals Inc.
GlobeNewswire
Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2023 Financial Results on March 21, 2024

Profile

Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.